4.6 Review

TSG101: A Novel Anti-HIV-1 Drug Target

期刊

CURRENT MEDICINAL CHEMISTRY
卷 17, 期 8, 页码 750-758

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986710790514444

关键词

TSG101; HIV-1; UEV; PTAP; budding; inhibitors; peptoid; cyclic peptide

资金

  1. National Natural Science Foundation of China [30873133, 30772629, 30371686]
  2. NSFC for International Cooperation [30910103908]
  3. Doctoral Program of Higher Education of China [070422083]

向作者/读者索取更多资源

The life cycle of HIV-1 requires extensive assistance from the host cell proteins and pathways. TSG101 is one of the cellular proteins involved in the budding process of HIV-1, and plays an important role in the cellular vacuolar protein sorting (Vps) pathway. Its main function being recognizing ubiquitinated cargo, TSG101 also proved to be essential for the budding process of HIV-1 virions. In this process, TSG101 is recruited from internal site of the infected cell to the budding site to aid in the release of the HIV-1 virus particles. Depletion of TSG101 from virus-producing cells can lead to a budding defect. Therefore, TSG101 is a potentially new attractive target for therapeutic intervention in AIDS. This review describes the structure and function of TSG101 and latest progress in the discovery of TSG101-directed HIV-1 inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据